Cargando…
Hematological Malignancy Patients, COVID-19, and Favipiravir
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Galenos Publishing
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656123/ https://www.ncbi.nlm.nih.gov/pubmed/34792305 http://dx.doi.org/10.4274/tjh.galenos.2021.2021.0582 |
| _version_ | 1784612217956597760 |
|---|---|
| author | Mungmunpuntipantip, Rujittika Wiwanitkit, Viroj |
| author_facet | Mungmunpuntipantip, Rujittika Wiwanitkit, Viroj |
| author_sort | Mungmunpuntipantip, Rujittika |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8656123 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Galenos Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86561232021-12-16 Hematological Malignancy Patients, COVID-19, and Favipiravir Mungmunpuntipantip, Rujittika Wiwanitkit, Viroj Turk J Haematol Letters to the Editor Galenos Publishing 2021-12 2021-12-07 /pmc/articles/PMC8656123/ /pubmed/34792305 http://dx.doi.org/10.4274/tjh.galenos.2021.2021.0582 Text en © Copyright 2021 by Turkish Society of Hematology / Turkish Journal of Hematology, Published by Galenos Publishing House. https://creativecommons.org/licenses/by/2.5/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letters to the Editor Mungmunpuntipantip, Rujittika Wiwanitkit, Viroj Hematological Malignancy Patients, COVID-19, and Favipiravir |
| title | Hematological Malignancy Patients, COVID-19, and Favipiravir |
| title_full | Hematological Malignancy Patients, COVID-19, and Favipiravir |
| title_fullStr | Hematological Malignancy Patients, COVID-19, and Favipiravir |
| title_full_unstemmed | Hematological Malignancy Patients, COVID-19, and Favipiravir |
| title_short | Hematological Malignancy Patients, COVID-19, and Favipiravir |
| title_sort | hematological malignancy patients, covid-19, and favipiravir |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656123/ https://www.ncbi.nlm.nih.gov/pubmed/34792305 http://dx.doi.org/10.4274/tjh.galenos.2021.2021.0582 |
| work_keys_str_mv | AT mungmunpuntipantiprujittika hematologicalmalignancypatientscovid19andfavipiravir AT wiwanitkitviroj hematologicalmalignancypatientscovid19andfavipiravir |